Cadence Pharmaceuticals™

Investor Relations

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recent Releases

Jun 22, 2009
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer

Jun 4, 2009
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009

Events

Jun 11, 2009
Eighth Annual Needham Life Sciences Conference

May 19, 2009
Deutsche Bank's 34th Annual Health Care Conference

more »
Print page Print
Email page Email


Stock Quote
CADX - (NASDAQ)
$10.26   + 0.02
Jul 2, 2009
4:02 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.

©2009 Cadence™ Pharmaceuticals. All rights reserved. No portion of cadencepharm.com may be duplicated, redistributed or manipulated in any form. CADENCE and ACETAVANCE are trademarks of Cadence Pharmaceuticals, Inc.